1. Wang, Yan, Ma, Binbin, Liu, Xiaoxu, Lin, Chengqi, Luo, Zhuojuan. 2022. ZFP281-BRCA2 prevents R-loop accumulation during DNA replication. In Nature communications, 13, 3493. doi:10.1038/s41467-022-31211-9. https://pubmed.ncbi.nlm.nih.gov/35715464/
2. Huang, Xin, Balmer, Sophie, Lyu, Cong, Zhou, Hongwei, Wang, Jianlong. 2024. ZFP281 controls transcriptional and epigenetic changes promoting mouse pluripotent state transitions via DNMT3 and TET1. In Developmental cell, 59, 465-481.e6. doi:10.1016/j.devcel.2023.12.018. https://pubmed.ncbi.nlm.nih.gov/38237590/
3. Chopp, Laura B, Zhu, Xiaoliang, Gao, Yayi, Zhu, Jinfang, Bosselut, Rémy. 2023. Zfp281 and Zfp148 control CD4+ T cell thymic development and TH2 functions. In Science immunology, 8, eadi9066. doi:10.1126/sciimmunol.adi9066. https://pubmed.ncbi.nlm.nih.gov/37948511/
4. Huang, Xin, Balmer, Sophie, Lyu, Cong, Zhou, Hongwei, Wang, Jianlong. 2023. ZFP281 coordinates DNMT3 and TET1 for transcriptional and epigenetic control in pluripotent state transitions. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.03.24.534143. https://pubmed.ncbi.nlm.nih.gov/36993548/
5. Guo, Jing, Xue, Zhonghui, Ma, Ruoyu, Lu, Linrong, Wang, Lie. 2019. The transcription factor Zfp281 sustains CD4+ T lymphocyte activation through directly repressing Ctla-4 transcription. In Cellular & molecular immunology, 17, 1222-1232. doi:10.1038/s41423-019-0289-y. https://pubmed.ncbi.nlm.nih.gov/31511645/
6. Nicolai, Sara, Pieraccioli, Marco, Smirnov, Artem, Melino, Gerry, Raschellà, Giuseppe. 2019. ZNF281/Zfp281 is a target of miR-1 and counteracts muscle differentiation. In Molecular oncology, 14, 294-308. doi:10.1002/1878-0261.12605. https://pubmed.ncbi.nlm.nih.gov/31782884/
智鼠故事 
